Molecular assays are a new type of molecular influenza diagnostic test to detect influenza viral RNA or nucleic acids in upper respiratory tract specimens in approximately 15-30 minutes.
This report contains market size and forecasts of Molecular Influenza Diagnostic in Global, including the following market information:
Global Molecular Influenza Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Molecular Influenza Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Reverse Transcription Polymerase Chain Reaction (RT-PCR) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Molecular Influenza Diagnostic include BD, Abbott (Include Alere), Roche, SIEMENS, Analytik Jena, Quidel, Thermo Fisher, Meridian Bioscience and BioMerieux, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Influenza Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Influenza Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Molecular Influenza Diagnostic Market Segment Percentages, by Type, 2021 (%)
Reverse Transcription Polymerase Chain Reaction (RT-PCR)
Nucleic Acid Sequence Based Amplification (NASBA) Tests
Loop-mediated Isothermal Amplification-Based Assays (LAMP)
Simple Amplification-based Assays (SAMBA)
Global Molecular Influenza Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Molecular Influenza Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals
POCT
Others
Global Molecular Influenza Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Molecular Influenza Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Influenza Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Molecular Influenza Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
Abbott (Include Alere)
Roche
SIEMENS
Analytik Jena
Quidel
Thermo Fisher
Meridian Bioscience
BioMerieux
Sekisui Diagnostics
Response Biomedical
SA Scientific